No capital raise coming. Costs for 200 technegas systems have already been spent.
Company is targeting 2025 to be cashflow positive.
Now that FDA approval has been granted, India should sit up and take notice.
Expect another announcement next week regarding a further indication of use for Beyond PE. As technegas has just been approved, a measured approached will be taken in terms of the speed of Beyond PE.
Ann: FDA Technegas Approval Webinar, page-11
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.60 |
Change
0.035(2.24%) |
Mkt cap ! $172.6M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.63 | $1.58 | $136.1K | 84.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 5836 | 1 |
View Market Depth
| Last trade - 15.42pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.59 |
Change
0.035 ( 0.95 %) |
||||
| Open | High | Low | Volume | ||
| $1.62 | $1.63 | $1.58 | 4788 | ||
| Last updated 15.41pm 07/06/2024 ? | |||||
| CYC (ASX) Chart |